Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Natalie A Hutnick

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Current Opinion in Virology|March 24, 2012
Selected approaches for increasing HIV DNA vaccine immunogenicity in vivoNatalie A Hutnick, Devin J F Myles, Chaoran Billie Bian, et al.
Vaccine|March 2, 2010
Adenovirus-specific human T cells are pervasive, polyfunctional, and cross-reactiveNatalie A Hutnick, Diane Carnathan, Korey Demers, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 19, 2011
Clinical applications of DNA vaccines: current progressBernadette Ferraro, Matthew P Morrow, Natalie A Hutnick, et al.
Medicine and Science in Sports and Exercise|November 16, 2005
Exercise and lymphocyte activation following chemotherapy for breast cancerNatalie A Hutnick, Nancy I Williams, William J Kraemer, et al.
Human Gene Therapy|June 2, 2012
Intradermal DNA vaccination enhanced by low-current electroporation improves antigen expression and induces robust cellular and humoral immune responsesNatalie A Hutnick, Devin J F Myles, Bernadette Ferraro, et al.
Human Vaccines & Immunotherapeutics|July 10, 2015
DNA vaccines targeting heavy chain C-terminal fragments of Clostridium botulinum neurotoxin serotypes A, B, and E induce potent humoral and cellular immunity and provide protection from lethal toxin challengeVeronica L Scott, Daniel O Villarreal, Natalie A Hutnick, et al.
Nature Medicine|July 22, 2009
Baseline Ad5 serostatus does not predict Ad5 HIV vaccine-induced expansion of adenovirus-specific CD4+ T cellsNatalie A Hutnick, Diane G Carnathan, Sheri A Dubey, et al.
Blood|June 10, 2009
AAV-1-mediated gene transfer to skeletal muscle in humans results in dose-dependent activation of capsid-specific T cellsFederico Mingozzi, Janneke J Meulenberg, Daniel J Hui, et al.
Plos One|January 5, 2011
Vaccination with Ad5 vectors expands Ad5-specific CD8 T cells without altering memory phenotype or functionalityNatalie A Hutnick, Diane G Carnathan, Sheri A Dubey, et al.
Journal of Virology|June 19, 2015
An Enhanced Synthetic Multiclade DNA Prime Induces Improved Cross-Clade-Reactive Functional Antibodies when Combined with an Adjuvanted Protein Boost in Nonhuman PrimatesMegan C Wise, Natalie A Hutnick, Justin Pollara, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Current Opinion in Virology|March 24, 2012
Selected approaches for increasing HIV DNA vaccine immunogenicity in vivoNatalie A Hutnick, Devin J F Myles, Chaoran Billie Bian, et al.
Vaccine|March 2, 2010
Adenovirus-specific human T cells are pervasive, polyfunctional, and cross-reactiveNatalie A Hutnick, Diane Carnathan, Korey Demers, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 19, 2011
Clinical applications of DNA vaccines: current progressBernadette Ferraro, Matthew P Morrow, Natalie A Hutnick, et al.
Medicine and Science in Sports and Exercise|November 16, 2005
Exercise and lymphocyte activation following chemotherapy for breast cancerNatalie A Hutnick, Nancy I Williams, William J Kraemer, et al.
Human Gene Therapy|June 2, 2012
Intradermal DNA vaccination enhanced by low-current electroporation improves antigen expression and induces robust cellular and humoral immune responsesNatalie A Hutnick, Devin J F Myles, Bernadette Ferraro, et al.
Human Vaccines & Immunotherapeutics|July 10, 2015
DNA vaccines targeting heavy chain C-terminal fragments of Clostridium botulinum neurotoxin serotypes A, B, and E induce potent humoral and cellular immunity and provide protection from lethal toxin challengeVeronica L Scott, Daniel O Villarreal, Natalie A Hutnick, et al.
Nature Medicine|July 22, 2009
Baseline Ad5 serostatus does not predict Ad5 HIV vaccine-induced expansion of adenovirus-specific CD4+ T cellsNatalie A Hutnick, Diane G Carnathan, Sheri A Dubey, et al.
Blood|June 10, 2009
AAV-1-mediated gene transfer to skeletal muscle in humans results in dose-dependent activation of capsid-specific T cellsFederico Mingozzi, Janneke J Meulenberg, Daniel J Hui, et al.
Plos One|January 5, 2011
Vaccination with Ad5 vectors expands Ad5-specific CD8 T cells without altering memory phenotype or functionalityNatalie A Hutnick, Diane G Carnathan, Sheri A Dubey, et al.
Journal of Virology|June 19, 2015
An Enhanced Synthetic Multiclade DNA Prime Induces Improved Cross-Clade-Reactive Functional Antibodies when Combined with an Adjuvanted Protein Boost in Nonhuman PrimatesMegan C Wise, Natalie A Hutnick, Justin Pollara, et al.
Pageof 2